Floatz logo

(+)-VINCRISTINE

Leukemia, T-Cell

Children's Oncology GroupSmall moleculePhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Leukemia, T-Cell cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Xinqiao Hospital of Chongqing
Phase 2B
PEGASPARGASE
Children's Oncology Group
Phase 2B
METHOTREXATE
Children's Oncology Group
Phase 2B
Cytosin-Arabinosid
Children's Oncology Group
Phase 2B
A-DMDT390-BISFV(UCHT1)
Virogen Biotechnology Inc.
Phase 2CCC

View all 29 →

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →